Health
Roche Expands Drug Development with China
Roche has entered into a significant deal with China's Hansoh Pharmaceutical Group to develop antibody-drug conjugates. This collaboration aims to expand Roche’s portfolio of potential new drugs.
Coverage timeline — 1 article
STAT News
China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.
2026-10-20 16:42 UTC